Stay updated on Cabozantinib in Solid Tumors & HIV Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Solid Tumors & HIV Clinical Trial page.

Latest updates to the Cabozantinib in Solid Tumors & HIV Clinical Trial page
- Check3 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3. This appears to be a minor update that does not modify the study details, eligibility criteria, or participant information.SummaryDifference0.0%

- Check10 days agoChange DetectedThe page shows a revision update from v3.6.0 to v3.6.2, indicating a minor release. The change is cosmetic and does not modify the study details or presented information.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check24 days agoChange DetectedNew sections 'How to Read a Study Record,' 'Common Questions,' 'How to Join a Study,' and an updated 'Intervention/Treatment' heading have been added, while the older 'Intervention / Treatment' heading and the 'Revision: v3.5.5' tag were removed. The page now shows 'No longer looking for participants' to indicate that recruitment for this study has ended, along with a new 'Revision: v3.6.0' tag.SummaryDifference0.3%

- Check32 days agoChange DetectedA new revision tag v3.5.5 was added and the previous v3.5.4 removed, updating the page's revision history. This denotes a minor maintenance update rather than any substantive change to the study data or content.SummaryDifference0.0%

- Check53 days agoChange DetectedA new revision label v3.5.4 was added, replacing the previous v3.5.3. This reflects a minor update to the page’s revision/version information.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page footer/version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a documentation or platform release rather than a change to the trial details.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib in Solid Tumors & HIV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Solid Tumors & HIV Clinical Trial page.